In conclusion, p53 and its isoforms are key factors in mediating cell response and cell sensitivity to treatment in RCC, though more studies are required to better understand the role of network interactions between p53 and its isoforms in this cancer. The gene discussed is TP53; the disease is renal cell carcinoma.